# Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)

> **NCT02373293** · — · UNKNOWN · sponsor: **Francisco Javier García Borobia** · enrollment: 400 (estimated)

## Conditions studied

- Acute Pancreatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02373293
- **Lead sponsor:** Francisco Javier García Borobia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-18
- **Primary completion:** 2015-01-30
- **Final completion:** 2017-08-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2017-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02373293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02373293, "Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02373293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*